Gruppo Oncologico Dell'Italia Meridionale

4 trials 4 recruiting Academic / non-commercial

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

4 Recruiting

0 Completed trials

2 Countries active

10 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III: 1 Phase II: 3

Oversight events:

2 corrective measures across 2 trials

View oversight register →

Top IMPs

TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE 2

All trials

4 total

ROMANCE Recruiting

2025-521319-38-00 Phase II 1 country TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE
CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected met… Recruiting

2024-519322-20-00 Phase III 2 countries
A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type… Recruiting

2024-519481-44-00 Phase II 1 country
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 Phase II 1 country TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE

Showing 1–4 of 4 trials

← All sponsors A–Z